Literature DB >> 30279774

Primary cardiac rhabdomyosarcoma developed after receiving radiotherapy for left breast cancer 18 years prior.

Satomi Suehiro1, Morihiro Matsuda1,2, Taizo Hirata3, Daiki Taniyama4, Kazuya Kuraoka4, Tai-Ichi Takasaki5, Takatsugu Segawa1, Toshiharu Oka1, Ritsu Tamura1, Hiroshi Sugino1.   

Abstract

The heart is an organ where primary malignant tumors rarely develop. In particular, the incidence of cardiac rhabdomyosarcoma (RMS) is extremely low. It has been reported that the risk of second malignant tumors in mediastinum is increased by radiotherapy in women with breast cancer. However, little is known about the association between irradiation to heart and cardiac RMS. Here, we report a case of a 68-year-old woman with primary cardiac RMS. She suddenly presented syncope at a workplace, and was taken to the emergency room at our hospital. Several imaging tests, including echocardiogram and cine magnetic resonance imaging, detected two tumors in the right ventricle (RV) and its outflow tract, which had almost obstructed the main trunk of the pulmonary artery (PA). To avoid sudden PA occlusion by the tumor, we emergently performed surgical excision of the tumors from the RV. Pathological analysis revealed that these tumors were embryonal type RMS. She had received radiotherapy after mastectomy for left breast cancer 18 years previously, and no recurrence of breast cancer had been detected. This cardiac RMS is considered as a second malignant tumor related to radiotherapy for breast cancer. <Learning objective: We experienced a 68-year-old woman having two tumors of the RMS in RV, who had received radiotherapy for left breast cancer 18 years previously and had previously presented no recurrence. There is literature suggesting that radiotherapy may increase the risk of soft-tissue sarcoma in women with breast cancer. We should be aware of cardiac RMS as a second malignant tumor related to radiotherapy for breast cancer, although its incidence is extremely low.>.

Entities:  

Keywords:  Breast cancer; Primary cardiac tumor; Radiotherapy; Rhabdomyosarcoma

Year:  2017        PMID: 30279774      PMCID: PMC6147380          DOI: 10.1016/j.jccase.2017.01.003

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

Review 1.  Primary cardiac tumors--French studies of 533 cases.

Authors:  P Blondeau
Journal:  Thorac Cardiovasc Surg       Date:  1990-08       Impact factor: 1.827

2.  Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma.

Authors:  J Huang; W J Mackillop
Journal:  Cancer       Date:  2001-07-01       Impact factor: 6.860

3.  Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients.

Authors:  Anna Virtanen; Eero Pukkala; Anssi Auvinen
Journal:  Int J Cancer       Date:  2006-02-15       Impact factor: 7.396

Review 4.  Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients.

Authors:  Trine Grantzau; Jens Overgaard
Journal:  Radiother Oncol       Date:  2014-11-07       Impact factor: 6.280

Review 5.  Rhabdomyosarcoma in children.

Authors:  Andrea Hayes-Jordan; Richard Andrassy
Journal:  Curr Opin Pediatr       Date:  2009-06       Impact factor: 2.856

6.  Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood.

Authors:  Axelle Menu-Branthomme; Carole Rubino; Akhtar Shamsaldin; Michael M Hawkins; Emmanuel Grimaud; Marie-Gabrielle Dondon; Claire Hardiman; Gilles Vassal; Sarah Campbell; Xavier Panis; Nicolas Daly-Schveitzer; Jean-Leon Lagrange; Jean-Michel Zucker; Jean Chavaudra; Olivier Hartman; Florent de Vathaire
Journal:  Int J Cancer       Date:  2004-05-20       Impact factor: 7.396

7.  Primary cardiac tumors.

Authors:  N A Silverman
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

8.  Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG).

Authors:  Trine Grantzau; Lene Mellemkjær; Jens Overgaard
Journal:  Radiother Oncol       Date:  2013-02-08       Impact factor: 6.280

9.  Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array.

Authors:  Riki Nishimura; Junko Takita; Aiko Sato-Otsubo; Motohiro Kato; Katsuyoshi Koh; Ryoji Hanada; Yukichi Tanaka; Keisuke Kato; Daichi Maeda; Masashi Fukayama; Masashi Sanada; Yasuhide Hayashi; Seishi Ogawa
Journal:  Cancer Sci       Date:  2013-05-23       Impact factor: 6.716

10.  Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.

Authors:  M M Hawkins; L M Wilson; H S Burton; M H Potok; D L Winter; H B Marsden; M A Stovall
Journal:  J Natl Cancer Inst       Date:  1996-03-06       Impact factor: 13.506

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.